BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mao W, Yin H, Chen W, Zhao T, Wu S, Jin H, Du B, Tan Y, Zhang R, He Y. Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma. Drug Des Devel Ther 2020;14:2135-47. [PMID: 32546976 DOI: 10.2147/DDDT.S249651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo Z, Yin H, Wu T, Wu S, Liu L, Zhang L, He Y, Zhang R, Liu N. Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation. J Ethnopharmacol 2022;293:115280. [PMID: 35405252 DOI: 10.1016/j.jep.2022.115280] [Reference Citation Analysis]
2 Siraj MA, Islam MA, Al Fahad MA, Kheya HR, Xiao J, Simal-gandara J. Cancer Chemopreventive Role of Dietary Terpenoids by Modulating Keap1-Nrf2-ARE Signaling System—A Comprehensive Update. Applied Sciences 2021;11:10806. [DOI: 10.3390/app112210806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xi P, Niu Y, Zhang Y, Li W, Gao F, Gu W, Kui F, Liu Z, Lu L, Du G. The mechanism of dioscin preventing lung cancer based on network pharmacology and experimental validation. J Ethnopharmacol 2022;:115138. [PMID: 35245631 DOI: 10.1016/j.jep.2022.115138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bandopadhyay S, Anand U, Gadekar VS, Jha NK, Gupta PK, Behl T, Kumar M, Radha, Shekhawat MS, Dey A. Dioscin: A review on pharmacological properties and therapeutic values. Biofactors 2021. [PMID: 34919768 DOI: 10.1002/biof.1815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
5 Chen SY, Zhang GC, Shu QJ. Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway. Pharm Biol 2021;59:1294-304. [PMID: 34543169 DOI: 10.1080/13880209.2021.1972122] [Reference Citation Analysis]
6 Zhu J, Lv J, Chen J, Zhang X, Ji Y. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Cell Cycle 2020;19:2851-65. [PMID: 33064959 DOI: 10.1080/15384101.2020.1827189] [Reference Citation Analysis]
7 Jin W, Yin H, Li H, Yu XJ, Xu HX, Liu L. Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR/ERK pathway. J Cell Mol Med 2021;25:5443-56. [PMID: 33955688 DOI: 10.1111/jcmm.16555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Singla RK, Behzad S, Khan J, Tsagkaris C, Gautam RK, Goyal R, Chopra H, Shen B. Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies. Front Pharmacol 2022;13:801733. [PMID: 35264951 DOI: 10.3389/fphar.2022.801733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]